Cardiac Surgery Market Size, Share & Trends Analysis | Global | 2025-2032 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 20 more

Product Description

The global cardiac surgery market was valued at $21.1 billion in 2025. This is expected to increase over the forecast period to reach $30.8 billion.

The full report suite on the global market for cardiac surgery devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair devices, transcatheter tricuspid valve repair devices, transcatheter heart valve replacement devices, cerebral embolic protection devices, balloon valvuloplasty devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, autotransfusion devices, endoscopic vessel harvesting devices, anastomosis assist devices, ventricular assist devices, intra-aortic balloon devices, artificial heart replacement devices, patent foramen ovale closure devices, patent ductus arteriosus closure devices, atrial and ventricular septal defect closure devices, left atrial appendage closure devices, preshaped guidewires and the extracorporeal membrane oxygenation (ECMO) market. The transmyocardial revascularization market is included as an appendix at the end of the report.

The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

Data Types Included

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2032, and Historical Data to 2022
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

Global Cardiac Surgery Device Market Trends

Ongoing advancements in cardiac diagnostic technologies, particularly computed tomography (CT) and magnetic resonance imaging (MRI), have enhanced the early and accurate identification of structural heart and valvular diseases. Historically, many patients with valve disorders were diagnosed only after disease progression and symptom onset; however, broader adoption of advanced imaging and routine cardiovascular evaluations is enabling earlier detection of abnormalities. As a result, the diagnosed patient population is expanding, leading to increased referrals for surgical and transcatheter interventions. This trend is supporting growth in procedural volumes and contributing to sustained demand for cardiac surgery and associated device markets globally.

Global Cardiac Surgery Device Market Share Insights

• Abbott emerged as the leading competitor in the global cardiac surgery device market in 2025. The company maintains a broad and diversified product portfolio across multiple cardiac surgery segments and competes strongly in most geographic markets. As a major global medical device manufacturer, Abbott is well positioned to further expand market share within its cardiac surgery division. In August 2025, Abbott’s Navitor™ transcatheter aortic valve implantation (TAVI) system received CE Mark approval for an expanded indication to treat a broader population with aortic stenosis. Additionally, Abbott obtained regulatory approval for its TriClip® system in Japan in July 2025, which is expected to further strengthen the company’s position in the transcatheter mitral and tricuspid intervention markets over the forecast period.
• Edwards Lifesciences was the second-leading competitor in the global cardiac surgery device market in 2025. Although the company participates in five cardiac surgery segments, it maintained a leading position in the majority of these segments, with the exception of transcatheter mitral and tricuspid valve repair devices. In May 2025, the company’s SAPIEN 3 transcatheter aortic valve replacement (TAVR) platform received FDA approval for the treatment of patients with asymptomatic severe aortic stenosis, further reinforcing its position in the structural heart market.
• Medtronic was the third-leading competitor in the global cardiac surgery device market in 2025. Its position is supported by a broad product portfolio spanning tissue and mechanical heart valves, annuloplasty repair systems, transcatheter heart valves, ONCAB/OPCAB devices, autotransfusion systems, and preshaped guidewires. In 2024, Medtronic launched the VitalFlow™ ECMO system and introduced Avalus Ultra™, its next-generation surgical aortic tissue valve. Supported by continued product innovation, the company is expected to maintain a strong market presence over the forecast period.

Global Cardiac Surgery Device Market Segmentation Summary

• Tissue Heart Valve Market – Further Segmented Into:
  • Device Type: Stented, Stentless, and Sutureless Heart Valves.
• Mechanical Heart Valve Market 
• Annuloplasty Repair Device Market 
• Transcatheter Mitral Valve Repair (TMVr) Market
• Transcatheter Tricuspid Valve Repair
• Transcatheter Heart Valve Replacement Market – Further Segmented Into:
  • Device Type: Transcatheter Aortic Valve Replacement, and  Transcatheter Pulmonary Valve Replacement.
• Cerebral Embolic Protection Device Market 
• Balloon Valvuloplasty Device Market – Further Segmented Into:
  • Device Type: Aortic, Mitral, and Pulmonary Devices.
• On-Pump Coronary Artery Bypass Device Market – Further Segmented Into:
  • Device Type: ONCAB Disposables, and Perfusion Systems.
• Off-Pump Coronary Artery Bypass Device Market – Further Segmented Into:
  • Device Type: Stabilizer Devices, and Positioners.
• Autotransfusion Device Market – Further Segmented Into:
  • Device Type: Autotransfusion Machines, and Autotransfusion Disposables.
• Endoscopic Vessel Harvesting Device Market 
• Anastomosis Assist Device Market 
• Ventricular Assist Device Market – Further Segmented Into:
  • Device Type: Implantable and Percutaneous VADs.
• Intra-Aortic Balloon Device Market – Further Segmented Into:
  • Device Type: IAB Catheters and IABP Consoles.
• Artificial Heart Replacement Device Market
• Patent Foramen Ovale Closure Device Market 
• Patent Ductus Arteriosus Closure Device Market 
• Atrial & Ventricular Septal Defect Closure Device Market – Further Segmented Into:
  • Device Type: Atrial Septal, and Ventricular Septal Defect Closure Devices.
• Left Atrial Appendage Closure Device Market – Further Segmented Into:
  • Device Type: Endocardial, Epicardial Clip, and Epicardial Suture LAA Devices.
• Preshaped Guidewire Market*
• Extracorporeal Membrane Oxygenation Market – Further Segmented Into:
  • Device Type: ECMO Disposables, and ECMO Machines.
• Transmyocardial Revascularization Device Market**

*This segment is indicated for TAVR.

**This segment is captured as an Appendix.

Research Scope Summary